Similar articles for PMID: 10706891

Year	Number of Results
1979	1
1990	1
1992	2
1993	3
1994	6
1995	11
1996	9
1997	6
1998	7
1999	10
2000	13
2001	5
2002	9
2003	2
2004	4
2005	3
2006	1
2007	2
2008	1
2009	3
2010	1
2011	2
2012	2
2013	1
2014	1
2015	2
2016	3
2017	2
2018	1
2019	2
2020	2
2024	0

1

Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer.

Stiff P, Chen B, Franklin W, Oldenberg D, Hsi E, Bayer R, Shpall E, Douville J, Mandalam R, Malhotra D, Muller T, Armstrong RD, Smith A. Stiff P, et al. Blood. 2000 Mar 15;95(6):2169-74. Blood. 2000. PMID: 10706891 Free article. Clinical Trial.

2

Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy.

Engelhardt M, Douville J, Behringer D, Jähne A, Smith A, Henschler R, Lange W. Engelhardt M, et al. Bone Marrow Transplant. 2001 Feb;27(3):249-59. doi: 10.1038/sj.bmt.1702788. Bone Marrow Transplant. 2001. PMID: 11277172

3

Ex-vivo expansion of bone marrow progenitor cells for hematopoietic reconstitution following high-dose chemotherapy for breast cancer.

Bachier CR, Gokmen E, Teale J, Lanzkron S, Childs C, Franklin W, Shpall E, Douville J, Weber S, Muller T, Armstrong D, LeMaistre CF. Bachier CR, et al. Exp Hematol. 1999 Apr;27(4):615-23. doi: 10.1016/s0301-472x(98)00085-x. Exp Hematol. 1999. PMID: 10210319 Free article. Clinical Trial.

4

Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer.

Williams SF, Lee WJ, Bender JG, Zimmerman T, Swinney P, Blake M, Carreon J, Schilling M, Smith S, Williams DE, Oldham F, Van Epps D. Williams SF, et al. Blood. 1996 Mar 1;87(5):1687-91. Blood. 1996. PMID: 8634412 Free article. Clinical Trial.

5

CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer.

Papadopoulos KP, Ayello J, Reiss RF, Troxel A, Kaufman E, Vahdat LT, Antman KH, Hesdorffer CS. Papadopoulos KP, et al. J Hematother Stem Cell Res. 1999 Aug;8(4):357-63. doi: 10.1089/152581699320117. J Hematother Stem Cell Res. 1999. PMID: 10634173 Clinical Trial.

6

A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy.

Shpall EJ, LeMaistre CF, Holland K, Ball E, Jones RB, Saral R, Jacobs C, Heimfeld S, Berenson R, Champlin R. Shpall EJ, et al. Blood. 1997 Dec 1;90(11):4313-20. Blood. 1997. PMID: 9373242 Free article. Clinical Trial.

7

Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support.

Papadopoulos KP, Ayello J, Tugulea S, Heitjan DF, Williams C, Reiss RF, Vahdat LT, Suciu-Foca N, Antman KH, Hesdorffer CS. Papadopoulos KP, et al. J Hematother. 1997 Feb;6(1):61-8. doi: 10.1089/scd.1.1997.6.61. J Hematother. 1997. PMID: 9112219 Clinical Trial.

8

A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation.

Pecora AL, Stiff P, LeMaistre CF, Bayer R, Bachier C, Goldberg SL, Parthasarathy M, Jennis AA, Smith AK, Douville J, Chen B, Armstrong RD, Mandalam RK, Preti R. Pecora AL, et al. Bone Marrow Transplant. 2001 Aug;28(3):295-303. doi: 10.1038/sj.bmt.1703137. Bone Marrow Transplant. 2001. PMID: 11535999 Clinical Trial.

9

An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy.

Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, West W. Weaver CH, et al. Blood. 1995 Nov 15;86(10):3961-9. Blood. 1995. PMID: 7579367 Free article. Clinical Trial.

10

Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer.

McNiece I, Jones R, Bearman SI, Cagnoni P, Nieto Y, Franklin W, Ryder J, Steele A, Stoltz J, Russell P, McDermitt J, Hogan C, Murphy J, Shpall EJ. McNiece I, et al. Blood. 2000 Nov 1;96(9):3001-7. Blood. 2000. PMID: 11049977 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year